Letter from AW Barrell to Dr Vaughan about the issue to supply of products made from human blood plasma to hospitals in Britain. The document outlines that there is a good chance of Travenol Laboratories being interested in operating a commercial fractionation unit. Also highlights the possibility of Travenol Laboratories taking a decision to invest in plasma fractionation elsewhere in Europe.